| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1724 | 2020 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1639 | 2020 |
| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1618 | 2020 |
| Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ... New England Journal of Medicine 383 (16), 1544-1555, 2020 | 1215 | 2020 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1197 | 2020 |
| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1167 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 999 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 963 | 2020 |
| The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020 | 962 | 2020 |
| A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures KH Dinnon III, SR Leist, A Schäfer, CE Edwards, DR Martinez, ... Nature 586 (7830), 560-566, 2020 | 736 | 2020 |
| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 593* | 2021 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 582 | 2021 |
| Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice AJ Pruijssers, AS George, A Schäfer, SR Leist, LE Gralinksi, KH Dinnon, ... Cell reports 32 (3), 2020 | 526 | 2020 |
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ... Nature medicine 26 (9), 1422-1427, 2020 | 512 | 2020 |
| Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans G Alter, J Yu, J Liu, A Chandrashekar, EN Borducchi, LH Tostanoski, ... Nature 596 (7871), 268-272, 2021 | 347 | 2021 |
| In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies D Li, RJ Edwards, K Manne, DR Martinez, A Schäfer, SM Alam, K Wiehe, ... Cell 184 (16), 4203-4219. e32, 2021 | 346* | 2021 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020 | 344 | 2020 |
| Differential kinetics of immune responses elicited by Covid-19 vaccines AY Collier, J Yu, K McMahan, J Liu, A Chandrashekar, JS Maron, C Atyeo, ... New England Journal of Medicine 385 (21), 2010-2012, 2021 | 267 | 2021 |
| Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses KO Saunders, E Lee, R Parks, DR Martinez, D Li, H Chen, RJ Edwards, ... Nature 594 (7864), 553-559, 2021 | 263 | 2021 |
| Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm, W Shi, A Pegu, ... Science 373 (6556), eabh1766, 2021 | 225* | 2021 |
